Response to Letter Regarding Article, “Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Cardiovascular Disease: A Randomized Trial” [PDF]
Nancy A. Rigotti+5 more
openalex +1 more source
Varenicline for tobacco dependence: panacea or plight? [PDF]
Jill M. Williams+5 more
openalex +1 more source
Smoking Cessation Pharmacogenetics: Analysis of Varenicline and Bupropion in Placebo-Controlled Clinical Trials [PDF]
David P. King+8 more
openalex +1 more source
Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats [PDF]
Jade J. Bito‐Onon+4 more
openalex +1 more source
A gender perspective of smoking cessation's health and economic value in Jordanian women: using cost effectiveness model. [PDF]
Madae'en S+7 more
europepmc +1 more source
A Randomized Placebo-Controlled Trial of Varenicline for Smoking Cessation Allowing Flexible Quit Dates [PDF]
S. I. Rennard+7 more
openalex +1 more source
Design of a randomized tobacco cessation trial among FDNY World Trade Center responders in a lung cancer screening program. [PDF]
Goldfarb DG+10 more
europepmc +1 more source